221 related articles for article (PubMed ID: 31144533)
21. Circ_0085289 Alleviates the Progression of Periodontitis by Regulating let-7f-5p/SOCS6 Pathway.
Du W; Wang L; Liao Z; Wang J
Inflammation; 2021 Aug; 44(4):1607-1619. PubMed ID: 33710445
[TBL] [Abstract][Full Text] [Related]
22. HnRNPU-AS1 inhibits the proliferation, migration and invasion of HCC cells and induces autophagy through miR-556-3p/ miR-580-3p/SOCS6 axis.
Zhang L; Zhao Y; Guan H; Zhang D
Cancer Biomark; 2022; 34(3):443-457. PubMed ID: 35275521
[TBL] [Abstract][Full Text] [Related]
23. Long noncoding RNA MCM3AP-AS1 attenuates sepsis-induced cardiomyopathy by improving inflammation, oxidative stress, and mitochondrial function through mediating the miR-501-3p/CADM1/STAT3 axis.
Nie X; Deng W; Zhou H; Wang Z
Int Immunopharmacol; 2024 Feb; 128():111500. PubMed ID: 38237222
[TBL] [Abstract][Full Text] [Related]
24. Abnormal expression of long non-coding RNA FGD5-AS1 affects the development of ovarian cancer through regulating miR-107/RBBP6 axis.
Zhang W; Shi J; Liu G
Chin J Physiol; 2023; 66(3):171-180. PubMed ID: 37322627
[TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNA FGD5-AS1 alleviates childhood IgA nephropathy by targeting PTEN-mediated JNK/c-Jun signaling pathway via miR-196b-5p.
Sun Q; Liu X; Wang M; Fan J; Zeng H
Exp Cell Res; 2023 Mar; 424(1):113481. PubMed ID: 36641136
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA FGD5-AS1 promotes colorectal cancer cell proliferation, migration, and invasion through upregulating CDCA7 via sponging miR-302e.
Li D; Jiang X; Zhang X; Cao G; Wang D; Chen Z
In Vitro Cell Dev Biol Anim; 2019 Sep; 55(8):577-585. PubMed ID: 31332696
[TBL] [Abstract][Full Text] [Related]
27. Long Noncoding RNA FGD5-AS1 Knockdown Decrease Viability, Migration, and Invasion of Non-Small Cell Lung Cancer (NSCLC) Cells by Regulating the MicroRNA-944/MACC1 Axis.
Lv J; Li Q; Ma R; Wang Z; Yu Y; Liu H; Miao Y; Jiang S
Technol Cancer Res Treat; 2021; 20():1533033821990090. PubMed ID: 33550920
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA FGD5-AS1 promotes non-small cell lung cancer cell proliferation through sponging hsa-miR-107 to up-regulate FGFRL1.
Fan Y; Li H; Yu Z; Dong W; Cui X; Ma J; Li S
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31919528
[TBL] [Abstract][Full Text] [Related]
29. LncRNA FGD5-AS1 functions as an oncogene to upregulate GTPBP4 expression by sponging miR-873-5p in hepatocellular carcinoma.
Zhang N; Shen H; Huang S; Wang F; Liu H; Xie F; Jiang L; Chen X
Eur J Histochem; 2021 Nov; 65(4):. PubMed ID: 34783233
[TBL] [Abstract][Full Text] [Related]
30. Silencing of Long Non-Coding RNA FGD5-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer by Regulating the miR-493-5p/DDX5 Axis.
Cui F; Luo P; Bai Y; Meng J
Technol Cancer Res Treat; 2021; 20():1533033821990007. PubMed ID: 33550957
[TBL] [Abstract][Full Text] [Related]
31. Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axis.
Gao SJ; Ren SN; Liu YT; Yan HW; Chen XB
Mol Ther Oncolytics; 2021 Dec; 23():14-25. PubMed ID: 34589581
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA SLCO4A1-AS1 drives the progression of non-small-cell lung cancer by modulating miR-223-3p/IKKα/NF-κB signaling.
Li Q; Jiang B; Qi Y; Zhang H; Ma H
Cancer Biol Ther; 2020 Sep; 21(9):806-814. PubMed ID: 32687454
[TBL] [Abstract][Full Text] [Related]
33. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis.
Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D
Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241
[TBL] [Abstract][Full Text] [Related]
34. Mesenchymal stem cell-originated exosomal lncRNA HAND2-AS1 impairs rheumatoid arthritis fibroblast-like synoviocyte activation through miR-143-3p/TNFAIP3/NF-κB pathway.
Su Y; Liu Y; Ma C; Guan C; Ma X; Meng S
J Orthop Surg Res; 2021 Feb; 16(1):116. PubMed ID: 33549125
[TBL] [Abstract][Full Text] [Related]
35. LncRNA FGD5-AS1 reduces cardiomyocyte apoptosis and inflammation by modulating Akt and miR-223-3p expression.
Zhao Y; Wang C; Cui T; Wang Q; Xu Y; Miao C; Liu S
Am J Transl Res; 2022; 14(9):6175-6186. PubMed ID: 36247255
[TBL] [Abstract][Full Text] [Related]
36. LncRNA FGD5-AS1 accelerates intracerebral hemorrhage injury in mice by adsorbing miR-6838-5p to target VEGFA.
Jiang F; Liu X; Wang X; Hu J; Chang S; Cui X
Brain Res; 2022 Feb; 1776():147751. PubMed ID: 34902342
[TBL] [Abstract][Full Text] [Related]
37. LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p.
Aichen Z; Kun W; Xiaochun S; Lingling T
Apoptosis; 2021 Jun; 26(5-6):348-360. PubMed ID: 33974163
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of lncRNA DNAJC3-AS1 inhibits colon cancer via regulating miR-214-3p/LIVIN axis.
Han B; Ge Y; Cui J; Liu B
Bioengineered; 2020 Dec; 11(1):524-535. PubMed ID: 32352854
[TBL] [Abstract][Full Text] [Related]
39. LncRNA DCST1-AS1 inhibits PDLCs' proliferation in periodontitis and may bind with miR-21 precursor to upregulate PLAP-1.
Wang X; Wang Y
J Periodontal Res; 2021 Apr; 56(2):256-264. PubMed ID: 33533513
[TBL] [Abstract][Full Text] [Related]
40. Long-Noncoding RNA FGD5-AS1 Enhances the Viability, Migration, and Invasion of Glioblastoma Cells by Regulating the miR-103a-3p/TPD52 Axis.
Su D; Ji Z; Xue P; Guo S; Jia Q; Sun H
Cancer Manag Res; 2020; 12():6317-6329. PubMed ID: 32848452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
